Antibodies under a microscope

DHE43201

Research Grade Ivuxolimab

Description

PF-04518600, CAS: 2225940-98-5

Targets

ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134

Isotype/Mimetic

IgG2-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Naive display libraries derived from human B cells

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Animal-free discovery, In vitro recombinant expression